Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ФГУ Московский НИИ психиатрии Росздрава, 2ГУ Институт ревматологии РАМН, Москва
Список исп. литературыСкрыть список 1. Birnbaum K. The making of psychosis: the principles of structural analysis in psychiatry. Berlin, Springer, 1923. 2. Снежневский А.В. Клиническая психопатология. В кн.: Руководство по психиатрии. М.: Медицина, 1983. 3. Nemeroff CB. The neurobiology of depression. Sci Am 1998; 278: 42–9. 4. Kaufman J, Plotsky P, Nemeroff C, Charney D. Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psychiat 2000; 48: 778–90. 5. Вельтищев Д.Ю. Клинико-патогенетические закономерности ситуационных расстройств депрессивного спектра. Автореф. дис. ... докт. мед. наук. М., 2000. 6. Вельтищев Д.Ю., Ковалевская К.Б., Серавина О.Ф. Стресс и модус предрасположения в патогенезе расстройств депрессивного спектра. Психич. расстройства в общей мед. 2008; 2: 34–7. 7. Thesaurus linguae latinae. Vol. I. Lipsae, Teubnez, 1900. 8. Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to desease. Nat Neuroscience 2005; 6: 463–75. 9. Blackburn-Munro G, Blackburn-Munro R. Chronic pain, chronic stress and depression: coincidence or consequence. J Neuroendocrinol 2001; 13: 1009–23. 10. Ohman L, Bergdahl J, Nyberg L et al. Longitudinal analysis of the relation between moderate long-term stress and health. Stress Health 2007; 23: 131–8. 11. Henn FA, Vollmayr B. Stress models of depression: forming genetically vulnerable strains Neurosci Biobehav Rev 2005; 29 (4–5): 799–804. 12. Keller MC, Neale MC, Kendler KS. Association of different adverse life events with distinct patterns of depressive symptoms. Am J Psychiat 2007; 164: 1521–9. 13. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 2002; 41: 605–18. 14. Hanly JG, Fisk JD, McCurdy G. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2005; 32 (8): 1459–6. 15. Purandare KN, Wagle AC, Parker SR. Psychiatric morbidity in patients with systemic lupus erythematosus. Q J Med 1999; 92: 283–6. 16. Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus. Neurology 2002; 58: 1214–20. 17. Iverson GL. Screening for depression in systemic lupus erythematosus with the British Columbia Major Depression Inventory. Psychol Rep 2002; 90 (3): 1091–6. 18. Da Costa D, Dobkin PL, Pinard L. The role of stress in functional disability among women with systemic lupus erythematosus: a prospective study. Arthritis Care Res 1999; 12 (2): 112–9. 19. Ishikura R, Morimoto N, Tanaka K et al. Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol 2001; 20 (6): 394–400. 20. Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol 2005; 32 (9): 1706–8. 21. Лисицына Т.А., Ковалевская О.Б., Серавина О.Ф. и др. Системная красная волчанка и депрессия: патогенетические взаимосвязи. Тер. арх. 2006; 12: 82–5. 22. Вельтищев Д.Ю., Лисицына Т.А., Серавина О.Ф. и др. Расстройства тревожно-депрессивного спектра при системной красной волчанке: особенности диагностики и терапии антидепрессантами. Фарматека. (Спец. вып.) 2006; с. 20–6. 23. Pettipher E, Labasi J, Salter E et al. Regulation of tumor necrosis factor production by adrenal hormones in vivo: insights into the anti-infammatory activity of rolipram. Br J Pharmacol 1996; 117: 1530–4. 24. Shirayama Y, Mitsushio H, Takashima M et al. Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amigdala. Brain Res 1996; 739: 70–8. 25. Maes M, Song C, Lin A et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999; 20 (4): 370–9. 26. Suzuki E, Shintani F, Kanba S et al. Induction of interleukin-1 and and interleukin-1 receptor antagonist mRNA by chronic traetment with various psychotropics in widespread area of rat brain. Neurosci Lett 1996; 215: 201–4. 27. Anderson I, Edwards J. Recommendations on SSRI treatment of depressive disorders. Adv Psych Treatment 2001; 7: 170–80. 28. Mooney P, Oakley J, Ferriter M. Sertraline as a treatment for PTSD: a systematic review and meta-analysis. J Psych Med 2004; 21 (3): 100–3. 29. Rasmussen A, Lunde M, Poulsen D et al. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003; 44: 216–21. 30. Организационная модель помощи лицам, страдающим депрессиями, в условиях территориальной поликлиники. Методические рекомендации. Под ред. В.Н.Краснова. М., 2000. 31. Бек П., Ольсен Л., Нимеус А. Психометрические шкалы оценки суицидального риска. В кн.: Напрасная смерть: причины и профилактика самоубийств. М.: Смысл, 2005; с. 163–71. 32. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385–96. 33. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.